FLX Bio

Wall street bull color

Biotech

Rapt Therapeutics revives IPO, files to raise $75M

Rapt Therapeutics filed to raise up to $75 million in its IPO after postponing an earlier attempt to raise $86 million in August.

Amirah Al Idrus Oct 23, 2019 7:10am

Buterfly coming out of a cocoon

FLX Bio keeps it capital in RAPT Therapeutics rebrand

May 24, 2019 10:15am

Boston skyline from harbor

2018’s Fierce 15 on biotech investment and the next decade

Oct 3, 2018 11:06am